Disease | intestinal disease |
Comorbidity | C0007114|skin cancer |
Sentences | 7 |
PubMedID- 20005977 | Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease. |
PubMedID- 22584081 | Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease. |
PubMedID- 24183955 | Avoiding rash decision making: skin cancer screening of patients with inflammatory bowel disease. |
PubMedID- 21806945 | Increased risk of nonmelanoma skin cancers among individuals with inflammatory bowel disease. |
PubMedID- 24419479 | Association between thiopurine use and nonmelanoma skin cancers in patients with inflammatory bowel disease: a meta-analysis. |
PubMedID- 24193153 | Background: several studies have demonstrated an increased risk of nonmelanoma skin cancer (nmsc) in patients with inflammatory bowel disease, with the greatest risk in patients with crohn's disease (cd). |
PubMedID- 21296187 | Risk of nonmelanoma skin cancer in patients with inflammatory bowel disease who use thiopurines is not increased. |
Page: 1